Microbia (Cambridge, MA) rational drug designer focused on GI and cardiovascular therapeutics raised a $50M series F round. The financing was led by Ridgeback Capital and joined by Morgan Stanley Investment Management.
Fatal error: Call to undefined function php() in /home/onbiovcc/public_html/wp-content/themes/bx-blue-green/single.php on line 25
